Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
16 Sep 2014 Monitoring the Response of Bone Metastases to Treatment Using MRI and PET Imaging
15 Sep 2014 Genomic Analysis Reveals Targetable Kinase-Activating Alterations in Ph-like Acute Lymphoblastic Leukaemia Translational research - Haematologic malignancies
10 Sep 2014 Novel Immunotherapy Vaccine May Decrease Recurrence in HER2 Positive Breast Cancer Patients Breast cancer - Immuno-oncology
09 Sep 2014 New Guideline on Treating Women with Advanced, HER2-Negative Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
08 Sep 2014 Phase III Trial of Lenalidomide Plus Dexamethasone in Newly Diagnosed Multiple Myeloma Patients Who Are Not Candidates for Stem Cell Transplantation Haematologic malignancies - Anticancer agents & Biologic therapy
05 Sep 2014 FDA Approves Pembrolizumab for Advanced Melanoma Melanoma - Immuno-oncology
03 Sep 2014 Circulating Tumour Cell Clusters More Likely to Cause Metastasis Than Single Cells Breast cancer - Translational research
02 Sep 2014 Validation of Genome-Driven Integrated Classification of Breast Cancer Breast cancer - Translational research
01 Sep 2014 Adjuvant Irinotecan Shows Promise for Subset of Stage III Colon Cancer Patients Translational research - Gastrointestinal cancers - Anticancer agents & Biologic therapy
27 Aug 2014 Discovery of Novel Mechanism by Which Senescence is Evaded in Tumour Cells Translational research
26 Aug 2014 The Mutational Burden of Acral Melanoma Translational research - Melanoma
25 Aug 2014 High Concordance Between EGFR Mutations From ctDNA and Tumour Tissue in NSCLC Personalised medicine - Translational research - Lung and other thoracic tumours
21 Aug 2014 Researchers Develop Web-Based App to Predict Glioma Mutations Personalised medicine - Central nervous system malignancies
20 Aug 2014 Older Patients With Limited Life Expectancy Still Receiving Cancer Screenings Cancer prevention
19 Aug 2014 FDA Approves Bevacizumab to Treat Patients with Persistent, Recurrent or Metastatic Cervical Cancer Gynaecologic malignancies - Anticancer agents & Biologic therapy